Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMBINED USAGE OF DIABETES THERAPEUTIC AGENTS
Document Type and Number:
WIPO Patent Application WO/2017/126524
Kind Code:
A1
Abstract:
Provided is a medicinal drug capable of, for example, further reducing blood glucose, improving lipid metabolism, and reducing side effects. The medicinal drug is obtained by combining: compound (1) or a pharmaceutically acceptable salt thereof; and at least one drug selected from the group consisting of a dipeptidyl peptidase 4 inhibitor, a biguanide drug, a sodium-glucose transporter 2 inhibitor, a sulfonylurea drug, and an α-glucosidase inhibitor.

Inventors:
MATSUMOTO KOJI (JP)
TAKAHASHI KANAKO (JP)
YOSHITOMI TOMOMI (JP)
UBUKATA NAOKO (JP)
TAGUCHI TAKASHI (JP)
NAKATSUKA YASUHIKO (JP)
Application Number:
PCT/JP2017/001472
Publication Date:
July 27, 2017
Filing Date:
January 18, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DAIICHI SANKYO CO LTD (JP)
International Classes:
A61K31/4245; A61K31/155; A61K31/40; A61K31/403; A61K31/4162; A61K31/496; A61K31/4985; A61K31/513; A61K31/519; A61K31/522; A61K31/64; A61K45/00; A61P3/06; A61P3/10; A61P43/00
Foreign References:
JP2012224640A2012-11-15
US20070105959A12007-05-10
Other References:
NEW PHARMACOLOGY, 20 November 2012 (2012-11-20), pages 502, 503, ISBN: 978-4-524-26088-1
DAISUKE YABE ET AL.: "Incretin-based therapies: Appropriate use in the management of type 2 diabetes", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 252, no. 5, 2015, pages 591 - 598, ISSN: 0039-2359
MICHINORI SAKADA ET AL.: "SGLT2 Sogaiyaku no Drug Effec t", THE JOURNAL OF PRACTICAL PHARMACY, vol. 66, no. 7, 2015, ISSN: 0044-0035
Attorney, Agent or Firm:
ISHIBASHI, Koki et al. (JP)
Download PDF: